Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Heavy Cannabis Use Tied to Increased Head and Neck Cancer Risk

2.

Lymph node transfer reduces arm swelling after breast cancer surgery, study shows

3.

Glioblastoma cells can 'unstick' from their neighbors to become more deadly

4.

Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma

5.

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot